— Know what they know.
Not Investment Advice

PHH NASDAQ

Park Ha Biological Technology Co., Ltd.
1W: -6.5% 1M: -34.4% 3M: -52.6%
$0.39
Last traded 2025-11-24 — delisted
NASDAQ · Consumer Defensive · Household & Personal Products · $10.0M mcap · 5M float · 11.83% daily turnover · Short 42% of daily vol

Balance Sheet Trends

Total Assets
$3M +36.1% ▲
5Y CAGR: -75.0%
Total Liabilities
$2M +25.9% ▲
5Y CAGR: -74.3%
Shareholders Equity
$2M +48.8% ▲
5Y CAGR: -73.2%
Cash & Investments
$547K -47.0% ▼
5Y CAGR: -77.3%
Total Debt
$70K +123.5% ▲
5Y CAGR: -86.0%
Net Debt
-$477K +52.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2017FY2021FY2022FY2023FY2024
— Assets —
Cash$542M$73K$575K$1M$547K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$542M$73K$575K$1M$547K
Net Receivables$78M$80K$2M$711K$1M
Inventory$0$317K$94K$96K$71K
Other Current Assets$0$0$60K$233K$1M
Total Current Assets$620M$474K$2M$2M$3M
Property, Plant & Equip.$22M$107K$63K$70K$175K
Goodwill & Intangibles$476M$0$9K$8K$8K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets-$498M$14K$182K$10K$407
Total Non-Current Assets$498M$121K$254K$89K$239K
Total Assets$1.8B$594K$3M$2M$3M
— Liabilities —
Accounts Payable$0$89K$130K$197K$24K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$0$165K$1M$251K$326K
Other Current Liabilities$0$0$0$0$0
Total Current Liabilities$0$1M$2M$1M$2M
Long-Term Debt$147M$0$0$0$0
Other Non-Current Liab.-$147M$0$0$0$0
Total Non-Current Liabilities$147M$16K$0$9K$53K
Total Liabilities$147M$1M$2M$1M$2M
— Equity —
Common Stock$0$500$500$500$500
Retained Earnings-$3M-$1M-$927K-$105K$272K
Accumulated OCI-$9M-$49K-$46K-$44K$73K
Total Stockholders Equity$553M-$578K$150K$1M$2M
Total Liabilities & Equity$1.8B$594K$3M$2M$3M
— Key Metrics —
Total Debt$147M$35K$26K$31K$70K
Net Debt-$395M-$37K-$549K-$1M-$477K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms